✦ LIBER ✦

Fotemustine: A Third-Generation Nitrosourea for the Treatment of Recurrent Malignant Gliomas

✍ Scribed by Beauchesne, Patrick

Book ID: 111927935
Publisher: MDPI AG
Year: 2012
Tongue: English
Weight: 109 KB
Volume: 4
Category: Article
ISSN: 2072-6694
DOI: 10.3390/cancers4010077

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison of treatment results for re

A comparison of treatment results for recurrent malignant gliomas

✍ C. Nieder; A.L. Grosu; M. Molls 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Efficacy of stereotactic radiosurgery as

Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas

✍ Doo-Sik Kong; Jung-Il Lee; Kwan Park; Jong Hyun Kim; Do-Hoon Lim; Do-Hyun Nam 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract ## BACKGROUND The objective of this prospective cohort study was to determine the efficacy of stereotactic radiosurgery (SRS) as a salvage treatment in patients with recurrent malignant gliomas. ## METHODS Between January 2000 and December 2006, 114 consecutive patients were treated

Pilot Study of Local Autologous Tumor In

Pilot Study of Local Autologous Tumor Infiltrating Lymphocytes for the Treatment of Recurrent Malignant Gliomas

✍ Keith B. Quattrocchi; Claramae H. Miller; Sharon Cush; Stephan A. Bernard; Scott 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 291 KB

GliaSite Brachytherapy for Treatment of

GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas and Metastases: A Retrospective Single-institutional Analysis

✍ P.R. Dutta; C.F. Mesina; J. Lopinto; K. Judy; D. O'Rourke; P. LeRoux; M. Ingram; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Efficacy and safety of the third-generat

Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas

✍ Gaetano Corazzelli; Ferdinando Frigeri; Manuela Arcamone; Luigi Aloj; Gaetana Ca 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

A phase 1/2 study of orally administered

A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas

✍ William T. Couldwell; Amy A. Surnock; Alfonso J. Tobia; Bernard E. Cabana; Charl 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB